Publikationen in Zusammenarbeit mit Forschern von Eli Lilly and Company (7)

2024

  1. Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe

    Endocrine, Vol. 83, Núm. 3, pp. 585-593

2017

  1. Gefitinib and EGFR gene copy number aberrations in esophageal cancer

    Journal of Clinical Oncology, Vol. 35, Núm. 20, pp. 2279-2287

2014

  1. Gefitinib for oesophageal cancer progressing after chemotherapy (COG): A phase 3, multicentre, double-blind, placebo-controlled randomised trial

    The Lancet Oncology, Vol. 15, Núm. 8, pp. 894-904

2012

  1. Mice lacking δ-opioid receptors resist the development of diet-induced obesity

    FASEB Journal, Vol. 26, Núm. 8, pp. 3483-3492

2010

  1. κ-Opioid receptors control the metabolic response to a high-energy diet in mice

    FASEB Journal, Vol. 24, Núm. 4, pp. 1151-1159

2007

  1. The central melanocortin system directly controls peripheral lipid metabolism

    Journal of Clinical Investigation, Vol. 117, Núm. 11, pp. 3475-3488

1997

  1. Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels

    Endocrinology, Vol. 138, Núm. 12, pp. 5641-5644